Medicine and Dentistry
Ganglioneuroblastoma
98%
Pediatrics
78%
Neoplasm
74%
Rhabdomyosarcoma
50%
Soft Tissue Sarcoma
49%
Chemotherapy
31%
Adolescence
30%
Disease
26%
Radiation Therapy
21%
Event Free Survival
19%
Overall Survival
16%
Childhood Cancer
15%
Metastatic Carcinoma
15%
Pediatrics Patient
14%
Diagnosis
14%
Immunotherapy
12%
Synovial Sarcoma
12%
Connective Tissue Cancer
11%
Minimal Residual Disease
10%
Malignant Neoplasm
10%
Methylation
9%
Malignant Peripheral Nerve Sheath Tumor
9%
Surgery
8%
Messenger RNA
8%
Clinical Trial
8%
Wilms' Tumor
8%
Cell Line
8%
RNA Sequence
7%
Cancer
7%
Plasma Cell Granuloma
7%
Local Therapy
7%
Pediatric Cancer
7%
Magnetic Resonance Imaging
7%
Real-Time Polymerase Chain Reaction
6%
Catecholamine
6%
Fibrosarcoma
6%
Neurofibromatosis Type I
6%
Lymph Node
6%
Programmed Cell Death
6%
Gene Expression
6%
Oncology
6%
Biological Marker
5%
Cohort Analysis
5%
Solid Malignant Neoplasm
5%
T Cell
5%
Promoter Region
5%
Anaplastic Lymphoma Kinase
5%
Morphology
5%
Prospective Study
5%
Adrenal Gland
5%
Keyphrases
Neuroblastoma
100%
Tumor
46%
Pediatric Soft Tissue Sarcomas
41%
Pediatric
35%
Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
31%
Rhabdomyosarcoma
26%
High-risk Neuroblastoma
23%
Chemotherapy
20%
Event-free Survival
20%
Radiotherapy
19%
Working Diagnosis
18%
Pediatric Patients
16%
Overall Survival
16%
Pediatric Oncology
13%
Synovial Sarcoma
12%
Confidence Interval
12%
Minimal Residual Disease
12%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
10%
123I-MIBG
10%
Poor Outcome
9%
Quantitative PCR
9%
Netherlands
9%
Neurofibromatosis Type 1 (NF-1)
8%
Neurofibromatosis Type I
8%
Tumors in children
8%
Pediatric Tumors
7%
EPS-SG
7%
Older Adults
7%
Catecholamines
7%
PHOX2B
7%
Inflammatory Myofibroblastic Tumor
7%
Bone Marrow
7%
Dutch
7%
Group Experiences
7%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
7%
Nephroblastoma
7%
Preadolescent children
7%
Risk Factors
6%
Prognostic Factors
6%
Clinical Trials
6%
Infantile Fibrosarcoma
6%
Metastasis
6%
Metastatic Disease
6%
Methylation
5%
Nuclear Imaging
5%
Epigenetics
5%
Childhood Cancer
5%
Pediatric Population
5%
Immunohistochemical Analysis
5%
Neuroblastoma Cell Line
5%